Cough Syrup: Indian company not responsible for the death of 66 children with cough medicine? The Gambian government gave this information

Maiden Pharmaceuticals Cough Syrup : The Gambia has not yet confirmed that India’s Maiden Pharmaceuticals Cough Syrup  Children died with (Cough Syrup). Reuters gave this information with reference to the representative of Gambia’s Medicines Control Agency. He said that it was not confirmed that cough medicine was the cause of the death of 66 children due to kidney injury. An alert was issued regarding India’s cough syrup. The WHO possibly linked it to the deaths of 66 children in The Gambia. The warning was issued for Maiden Pharmaceuticals’ Promethazine Oral Solution, Cofaxmalin Baby Cough Syrup, Macoff Baby Cough Syrup and Magrip N Cold Syrup.

The company gave a clean 

WHO investigators found diethylene glycol and ethylene glycol in products "Unacceptable" found the level After this, Medan Pharmaceuticals Limited clarified the matter and said that we are not selling anything in the domestic market. We are procuring raw materials from certified and reputed companies. After this claim of WHO, the Central Drugs Standard Control Organization started an investigation.

Production in Haryana was closed Haryana state drug authorities later found irregularities during an inspection of Medan Pharma’s manufacturing facility and suspended production of the cough syrup in Sonepat district. Also, the expert committee of DCGI said in its first meeting on October 15 that the information shared by WHO so far about the treatment of children is not enough.

Note: You can download our app to read breaking news in Punjabi. If you want to watch the video, then subscribe to ABP’s YouTube channel. ABP sharing is available on all social media platforms. You can also follow us on Facebook, Twitter, Ku, ShareChat and DailyHunt.

Get the more latest news about India